{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:58:08Z","timestamp":1773262688535,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.clinimag.2022.03.006","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T12:06:09Z","timestamp":1646827569000},"page":"106-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Radiographic features of pneumonitis in patients treated with immunotherapy compared to traditional chemotherapy for non-small cell lung cancer"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6536-2673","authenticated-orcid":false,"given":"Kathleen M.","family":"Capaccione","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belinda","family":"D'souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Leb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyndon","family":"Luk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aileen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary M.","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.clinimag.2022.03.006_bb0005","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jtho.2019.05.044","article-title":"Lung cancer incidence and mortality with extended follow-up in the national lung screening trial","volume":"14","year":"2019","journal-title":"J Thorac Oncol"},{"issue":"18_suppl","key":"10.1016\/j.clinimag.2022.03.006_bb0010","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2006.24.18_suppl.7082","article-title":"Temporal trends in small cell lung cancer: analysis of the national Surveillance, Epidemiology, and End-Results (SEER) database","volume":"24","author":"Navada","year":"2006","journal-title":"J Clin Oncol"},{"issue":"5 Suppl","key":"10.1016\/j.clinimag.2022.03.006_bb0015","doi-asserted-by":"crossref","first-page":"e121S","DOI":"10.1378\/chest.12-2352","article-title":"Clinical and organizational factors in the initial evaluation of patients with lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Ost","year":"2013","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.clinimag.2022.03.006_bb0020","doi-asserted-by":"crossref","first-page":"e211S","DOI":"10.1378\/chest.12-2355","article-title":"Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Silvestri","year":"2013","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.clinimag.2022.03.006_bb0025","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/RTI.0000000000000219","article-title":"Imaging in advanced non-small cell lung cancer: a medical oncology perspective","volume":"31","author":"Dimou","year":"2016","journal-title":"J Thorac Imaging"},{"issue":"5","key":"10.1016\/j.clinimag.2022.03.006_bb0030","doi-asserted-by":"crossref","first-page":"e437S","DOI":"10.1378\/chest.12-2365","article-title":"Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Colt","year":"2013","journal-title":"Chest"},{"issue":"17","key":"10.1016\/j.clinimag.2022.03.006_bb0035","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non\u2013small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"New EnglJMed"},{"issue":"2","key":"10.1016\/j.clinimag.2022.03.006_bb0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non\u2013small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clinimag.2022.03.006_bb0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev-med-051718-013524","article-title":"Precision management of advanced non-small cell lung cancer","volume":"71","author":"Yang","year":"2020","journal-title":"Annu Rev Med"},{"issue":"35","key":"10.1016\/j.clinimag.2022.03.006_bb0050","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1200\/JCO.2017.74.3062","article-title":"Nivolumab versus docetaxel in previously treated patients with advanced non-small-cell lung cancer: two-year outcomes from two randomized, open-label, phase III trials (CheckMate 017 and CheckMate 057)","volume":"35","author":"Horn","year":"2017","journal-title":"J Clin Oncol"},{"issue":"9652","key":"10.1016\/j.clinimag.2022.03.006_bb0055","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0140-6736(08)61758-4","article-title":"Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial","volume":"372","author":"Kim","year":"2008","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.clinimag.2022.03.006_bb0060","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1200\/JCO.2005.02.840","article-title":"TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non\u2013small-cell lung cancer","volume":"23","author":"Herbst","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clinimag.2022.03.006_bb0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non\u2013small-cell lung cancer","volume":"378","author":"Soria","year":"2017","journal-title":"New EnglJMed"},{"issue":"15_suppl","key":"10.1016\/j.clinimag.2022.03.006_bb0070","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2014.32.15_suppl.8002","article-title":"First-line crizotinib versus pemetrexed\u2013cisplatin or pemetrexed\u2013carboplatin in patients (pts) with advanced ALK-positive non-squamous non-small cell lung cancer (NSCLC): results of a phase III study (PROFILE 1014)","volume":"32","author":"Mok","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinimag.2022.03.006_bb0075","article-title":"Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis","volume":"360","author":"Baxi","year":"2018","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.clinimag.2022.03.006_bb0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11912-020-00920-z","article-title":"Checkpoint inhibitor pneumonitis: mechanisms, characteristics, management strategies, and beyond","volume":"22","author":"Reuss","year":"2020","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.clinimag.2022.03.006_bb0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-3-030-02505-2_6","article-title":"Immune-related adverse events: pneumonitis","volume":"995","author":"Jain","year":"2018","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"10.1016\/j.clinimag.2022.03.006_bb0090","doi-asserted-by":"crossref","first-page":"W992","DOI":"10.2214\/AJR.10.6198","article-title":"Radiologic manifestations of immune-related adverse events in patients with metastatic melanoma undergoing anti-CTLA-4 antibody therapy","volume":"197","author":"Bronstein","year":"2011","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.clinimag.2022.03.006_bb0095","doi-asserted-by":"crossref","first-page":"44173","DOI":"10.1038\/srep44173","article-title":"PD-1 inhibitors increase the incidence and risk of pneumonitis in cancer patients in a dose-independent manner: a meta-analysis","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinimag.2022.03.006_bb0100","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920922033","article-title":"Association of immune-related pneumonitis with the efficacy of PD-1\/PD-L1 inhibitors in non-small cell lung cancer","volume":"12","author":"Cui","year":"2020","journal-title":"Ther Adv Med Oncol"},{"issue":"7","key":"10.1016\/j.clinimag.2022.03.006_bb0105","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1148\/rg.2019190036","article-title":"Immune checkpoint inhibitor therapy\u2013related pneumonitis: patterns and management","volume":"39","author":"Kalisz","year":"2019","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.clinimag.2022.03.006_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030305","article-title":"Immunotherapy associated pulmonary toxicity:biology behind clinical and radiological features","volume":"11","author":"Porcu","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.clinimag.2022.03.006_bb0115","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1158\/2326-6066.CIR-15-0102","article-title":"Radiographic profiling of immune-related adverse events in advanced melanoma patients treated with ipilimumab","volume":"3","author":"Tirumani","year":"2015","journal-title":"Cancer Immunol Res"},{"issue":"24","key":"10.1016\/j.clinimag.2022.03.006_bb0120","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1158\/1078-0432.CCR-16-1320","article-title":"PD-1 inhibitor-related pneumonitis in advanced cancer patients: radiographic patterns and clinical course","volume":"22","author":"Nishino","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"17","key":"10.1016\/j.clinimag.2022.03.006_bb0125","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1200\/JCO.2011.39.3298","article-title":"Pulmonary sarcoid-like granulomatosis induced by ipilimumab","volume":"30","author":"Berthod","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clinimag.2022.03.006_bb0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-5231(03)00123-0","article-title":"Chemotherapy-induced lung disease","volume":"25","author":"Limper","year":"2004","journal-title":"Clin Chest Med"},{"issue":"2","key":"10.1016\/j.clinimag.2022.03.006_bb0135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1179\/1973947815Y.0000000029","article-title":"Paclitaxel-induced pneumonitis in patients with breast cancer: case series and review of the literature","volume":"29","author":"Bielopolski","year":"2017","journal-title":"J Chemother"},{"issue":"5","key":"10.1016\/j.clinimag.2022.03.006_bb0140","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s10156-010-0058-4","article-title":"Severe interstitial pneumonitis associated with the administration of taxanes","volume":"16","author":"Nagata","year":"2010","journal-title":"J Infect Chemother"},{"issue":"10","key":"10.1016\/j.clinimag.2022.03.006_bb0145","first-page":"4357","article-title":"Carboplatin plus weekly paclitaxel treatment in non-small cell lung cancer patients with interstitial lung disease","volume":"30","author":"Shukuya","year":"2010","journal-title":"Anticancer Res"},{"issue":"9","key":"10.1016\/j.clinimag.2022.03.006_bb0150","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1054\/bjoc.2001.2071","article-title":"Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere)","volume":"85","author":"Wang","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clinimag.2022.03.006_bb0155","series-title":"Chi-square test calculator","year":"2021"},{"issue":"13","key":"10.1016\/j.clinimag.2022.03.006_bb0160","first-page":"1671","article-title":"First-line treatment for advanced non-small-cell lung cancer","volume":"19","author":"Laskin","year":"2005","journal-title":"Oncology (Williston Park)"},{"issue":"2","key":"10.1016\/j.clinimag.2022.03.006_bb0165","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chest.2017.04.177","article-title":"Incidence of pneumonitis with use of programmed death 1 and programmed death-ligand 1 inhibitors in non-small cell lung cancer: a systematic review and meta-analysis of trials","volume":"152","author":"Khunger","year":"2017","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.clinimag.2022.03.006_bb0170","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.2016.68.2005","article-title":"Pneumonitis in patients treated with anti-programmed death-1\/programmed death ligand 1 therapy","volume":"35","author":"Naidoo","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinimag.2022.03.006_bb0180","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejca.2017.12.013","article-title":"Pulmonary nodules and immunotherapy: disease progression or toxicity of anti-PD1\/anti-PDL1 checkpoint inhibitors?","volume":"93","author":"Pradere","year":"2018","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.clinimag.2022.03.006_bb0185","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S2213-2600(18)30172-3","article-title":"Diagnosis and management of pulmonary toxicity associated with cancer immunotherapy","volume":"6","author":"Rashdan","year":"2018","journal-title":"Lancet Respir Med"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707122000699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707122000699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:51:27Z","timestamp":1760269887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707122000699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":36,"alternative-id":["S0899707122000699"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2022.03.006","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiographic features of pneumonitis in patients treated with immunotherapy compared to traditional chemotherapy for non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2022.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}